Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
amgen
biotech
calcitonin gene-related peptide
chronic migraine
clinical trials
eli lilly
episodic migraine
fda
indiana blog main
indiana top stories
life sciences
national blog main
teva pharmaceutical
alder biopharmaceuticals
benevolentai
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
david rind
detroit blog main
detroit top stories
drugs
eptinezumab
erenumab
europe
food and drug administration
fremanezumab
galcanezumab
indiana
institute for clinical and economic review
migraine
migraine research foundation
migraines
national
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
What
drug
medicines
3
×
starts
3
×
approval
class
developed
fda
late
migraine
new
pain
won
accelerate
accelerating
achieve
actually
amgen
announced
approved
astrazeneca
benevolentai
candidates
clinical
collaboration
company
data
decision
development
discovery
early
eli
facili
focuses
founded
gets
head
headache
journey
lilly
look
Language
Current search:
starts
×
medicines
×
@techcrunch.com
4 years ago
BenevolentAI starts AI collaboration with AstraZeneca to accelerate drug discovery
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
5 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines
